<DOC>
	<DOCNO>NCT02519062</DOCNO>
	<brief_summary>This retrospective study involve revision clinical , instrumental pathologic data estimate cohort maximum 130 patient NSCLC treat surgery radical intent center .</brief_summary>
	<brief_title>Role FDG PET , Immune Hypoxic Marker NSCLC</brief_title>
	<detailed_description>This retrospective observation involve revision clinical , instrumental pathologic data estimate cohort 130 patient NSCLC treat surgery radical intent center . We review FDG-PET acquire within 30 day prior surgery analyze principal image characteristic respect hypoxic immune-related marker immunohistochemistry ( IHC ) . These marker study tumor tissue obtain surgery , use diagnostic purpose store paraffin .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Diagnosis NSCLC ( Stage IIII ) FDG PET surgery Absence tumor specimen No clinical data FDGPET evaluate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Carcinoma</keyword>
	<keyword>Non-Small-Cell Lung</keyword>
	<keyword>FDG PET</keyword>
	<keyword>hypoxia marker</keyword>
	<keyword>immune marker</keyword>
</DOC>